Open for Enrollment

Pediatric Studies

Primary Investigator : Zimmerman-Bier, Barbie
Study Name: A Phase III Randomized Double Blind Placebo Controlled Trial of LUMINENZ-AT™ (CM-AT) In Children with Autism